Cases & Deals

Baxter Ventures invests in Zytoprotec

Clients Baxter International Inc.

Jones Day advised Baxter Ventures in connection with its investment in Zytoprotec GmbH, an Austrian biotechnology company applying findings in the area of cytoprotection to develop new treatment options for major diseases.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.